Skip to main content

Table 1 Baseline characteristics of patients

From: A novel nomogram for predicting liver metastasis in patients with gastrointestinal stromal tumor: a SEER-based study

Characteristics

SEER cohort (%)

P

Entire cohort n = 3797

Training n = 2849

Testing

n = 948

Age

62.25 ± 13.67

62.12 ± 13.90

62.38 ± 13.43

0.616

Sex

   

0.962

 Male

1908(50.2)

1431(50.2)

477(47.1)

 

 Female

1889(49.8)

1418(49.8)

471(52.9)

 

Marriage

   

0.158

 Married

2143(56.4)

1609(56.4)

534(56.3)

 

 Unmarried

1447(38.1)

1096(38.4)

351(37.0)

 

 Unknown

207(5.5)

144(5.2)

6.6(6.7)

 

Race

   

0.359

 White

2534(66.7)

1909(67.0)

625(65.9)

 

 Black

684(18.0)

519(18.2)

165(17.4)

 

 Others

579(15.3)

421(14.8)

158(16.7)

 

Tumor location

   

0.716

 Stomach

1509(39.7)

1119(39.2)

390(41.1)

 

 Duodenum

213(5.6)

158(5.5)

55(5.8)

 

 Jejunum

272(7.1)

208(7.3)

64(6.7)

 

 Ileum

104(2.7)

86(3.0)

18(1.8)

 

 Colon

79(2.0)

60(2.1)

19(2.0)

 

 Rectum

104(2.7)

79(2.7)

25(2.6)

 

 Others

457(12.0)

340(11.9)

117(12.3)

 

 Unknown

1059(28.2)

799(28.3)

260(27.7)

 

Tumor size

   

0.003

  ≤ 2 cm

446(11.7)

356(12.4)

90(9.4)

 

 2–5 cm

1066(28.0)

797(27.9)

269(28.3)

 

 5–10 cm

1088(28.6)

839(29.4)

249(26.2)

 

  > 10 cm

896(23.5)

645(22.6)

251(26.4)

 

 Unknown

301(8.2)

212(7.7)

89(9.7)

 

N stage

   

0.319

 N0

3531(93.1)

2658(93.4)

873(92.2)

 

 N1

131(3.4)

97(3.4)

34(3.5)

 

 Unknown

135(3.5)

94(3.2)

41(4.3)

 

Mitotic rate

   

0.794

  < 5/50 HPFs

1835(48.3)

1386(48.6)

449(47.3)

 

  ≥ 5/50 HPFs

814(21.4)

610(21.4)

204(21.5)

 

 Unknown

1148(30.3)

853(30.0)

295(31.2)

 

Liver metastasis

   

0.823

 No

3368(88.7)

2529(88.7)

839(88.5)

 

 Yes

429(11.3)

320(11.3)

109(11.5)

 
  1. SEER Surveillance, Epidemiology, and End Results, HPFs high power fields